These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6132009)

  • 1. Preparation of some 10-[3-(dimethylamino)-1-propyl]-10H-pyrazino[2,3-b][1,4] benzothiazines as potential neuroleptics.
    Saari WS; Cochran DW; Lee YC; Cresson EL; Springer JP; Williams M; Totaro JA; Yarbrough GG
    J Med Chem; 1983 Apr; 26(4):564-9. PubMed ID: 6132009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives.
    Remy DC; Britcher SF; King SW; Anderson PS; Hunt CA; Randall WC; Bélanger P; Atkinson JG; Girard Y; Rooney CS; Fuentes JJ; Totaro JA; Robinson JL; Risley EA; Williams M
    J Med Chem; 1983 Jul; 26(7):974-80. PubMed ID: 6134835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted phenothiazine neuroleptics. 1. 3-(Dimethylamino)-1,2,3,4-tetrahydroazepino[3,2,1-kl]phenothiazine.
    Martin AR; Kim SH; Yamamura HI; Horn AS
    J Med Chem; 1980 Aug; 23(8):938-41. PubMed ID: 6105219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective labeling of pre-synaptic receptors by 3H-dopamine, 3H-apomorphine and 3H-clonidine; labeling of post-synaptic sites by 3H-neuroleptics.
    Titeler M; Tedesco JL; Seeman P
    Life Sci; 1978 Aug; 23(6):587-91. PubMed ID: 29197
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems.
    Chakrabarti JK; Hotten TM; Morgan SE; Pullar IA; Rackham DM; Risius FC; Wedley S; Chaney MO; Jones ND
    J Med Chem; 1982 Oct; 25(10):1133-40. PubMed ID: 6128416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents.
    Davis DA; de Paulis T; Janowsky A; Smith HE
    J Med Chem; 1990 Feb; 33(2):809-14. PubMed ID: 1967652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control of dopamine receptors in mouse caudate nucleus: relationship on cataleptic response to neuroleptic drugs.
    Fink JS; Swerdloff A; Reis DJ
    Neurosci Lett; 1982 Oct; 32(3):301-6. PubMed ID: 6129603
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of conformationally restricted phenothiazine analogues.
    Grol CJ; Dijkstra D; Schunselaar W; Westerink BH; Martin AR
    J Med Chem; 1982 Jan; 25(1):5-9. PubMed ID: 6123599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New detection of brain dopamine receptors with (3H)dihydroergocryptine.
    Tittler M; Weinreich P; Seeman P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3750-3. PubMed ID: 410026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral resolution and binding study of 1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzotriazepine (10-methyl-10-azaaptazepine) and 2-methyl-1,3,4,14b-tetrahydro-2H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzothiadiazepine 10,10-dioxide (tiaaptazepine).
    De Martino G; La Regina G; La Torre F; Cirilli R; Mereghetti I; Cagnotto A; Artico M; Silvestri R
    Farmaco; 2005; 60(11-12):931-7. PubMed ID: 16223499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Chloro-2-phenyl-1-benzo[b]thiophene-3-alkanimines, potential antipsychotic agents.
    Kukla MJ; Woo CM; Kehr JR; Miller A
    J Med Chem; 1978 Apr; 21(4):348-52. PubMed ID: 25967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common stereospecificity of opioid and dopamine systems for N-butyrophenone prodine-like compounds.
    Iorio MA; Frigeni V; Bowman ER; Harris LS; May EL; Aceto MD
    J Med Chem; 1991 Jan; 34(1):194-7. PubMed ID: 1671414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of antipsychotic drugs on dopamine-receptors on caudate calf].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):296-9, 317-8. PubMed ID: 1363315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.